UNIVERSITÉ D'AIX-MARSEILLE;INSERM (Institut National de la Santé et de la Recherche Médicale);Centre National de la Recherche Scientifique;INSTITUT CURIE
The invention relates to the use of cystamine, cysteamine, or a salt thereof, or of calcineurin inhibitors for treating a MeCP2-associated disorder such as Rett syndrome.